Hemangioma and Vascular Malformations Clinic
The Hemangioma and Vascular Malformations Clinic at Nationwide Children’s Hospital brings together a highly skilled interdisciplinary team of pediatric specialists to provide coordinated and comprehensive care for patients with vascular anomalies. Our specialists work in partnership with the primary care physician and collaborate in the evaluation, treatment and management of patients.
Our team is actively involved in research efforts leading to break-through of new therapeutic approaches to care for patients with vascular anomalies and hemangiomas.
Our Team Includes Specialists In:
Clinical Directors
Ibrahim Khansa
Ibrahim Khansa, MD, is a surgeon within the Department Plastic and Reconstructive Surgery at Nationwide Children's Hospital, and Assistant Professor of Plastic Surgery at The Ohio State University. He is the director of the Hemangioma and Vascular Malformations program, and a member of the Center for Complex Craniofacial Disorders and the Cleft Lip and Palate Team.
Anna P. Lillis
Anna Lillis, MD, PhD, is a pediatric interventional radiologist at Nationwide Children’s Hospital. She earned her medical degree and PhD in Pathology from Duke University in 2008. She completed Radiology Residency training at Brigham and Women’s Hospital and Pediatric Radiology Fellowship and advanced Pediatric Interventional Radiology training at Boston Children’s Hospital.
Services We Offer
- Comprehensive evaluation, diagnosis and management of hemangiomas and other vascular tumors, including pharmacologic treatment (timolol, propranolol, steroids), surgical treatment, laser therapy, surgical or image-guided biopsy and embolization
- Multidisciplinary approach to complex vascular anomalies, including slow flow (lymphatic malformations and venous malformations), high flow (arteriovenous fistulae and arteriovenous malformations), and combined malformations and overgrowth syndromes (such as Klippel-Trenaunay Syndrome, CLOVES, Capillary Malformation with Overgrowth and others)
- Our multidisciplinary team includes providers from Plastic Surgery, Diagnostic and Interventional Radiology, Dermatology, Hematology/Oncology, Orthopedic Surgery, Otolaryngology, Clinical Genetics, Psychology, Social Work and The Steve and Cindy Rasmussen Institute for Genomic Medicine
- Patients are discussed at our biweekly multidisciplinary conference which feature clinical case review and imaging discussion. Recommendations are made for further testing, if needed, including additional imaging, laboratory testing, and/or genetic screening. Treatment recommendations are provided including minimally-invasive image-guided sclerotherapy, embolization, biopsy with the possibility of genomic testing, targeted medical therapy, laser therapy and/or surgical resection or debulking.
- Complex patients may be seen by multiple specialists co-located at one visit during our monthly multidisciplinary clinic
- State-of-the-art imaging technology including ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), and fluoroscopic and MR lymphangiography to aid in diagnosis of vascular tumors and malformations and guide management
- Minimally-invasive, image-guide therapy including sclerotherapy and embolization by our team of expert Interventional Radiologists
- Targeted medical therapy that includes use of sirolimus (rapamycin), and monitoring for management of hemangiomas, vascular tumors and complex malformations by Dermatology and Hematology/Oncology teams
- Management and treatment of conditions affecting the nose, mouth and airway by our Otolaryngology (ENT) team
- Clinical genetic and genomic analysis for identification of causal genes leading to possible treatment with available and developing targeted medical therapies
- Laser therapy for certain malformations and birthmarks with skin involvement including Port Wine birthmarks and other capillary malformations, superficial venous malformations, etc.
- Management of orthopedic complications of vascular anomalies including leg-length discrepancy and joint involvement
- Surgical biopsy, resection or partial resection/debulking (partial removal of involved or overgrown tissue) of various tumors and malformations by our surgical specialists in Plastic Surgery, Otolaryngology and Orthopedic Surgery.
- Psychological evaluation and psychosocial support for our patients and families where needed by our dedicated Psychology and Social Work providers.
- Supportive care services that include physical therapy, occupational therapy and fitting for compression garments.
- Cutting edge research into advanced diagnostic and therapeutic techniques for vascular anomalies
Conditions We Treat
Our Clinics
Hemangioma and Vascular Malformations Clinic
(Located within Plastic Surgery Clinic)
700 Children's Drive, Suite T5E
Columbus, OH 43205
Phone: (614) 722-6299
Fax: (614) 722-5826
Interventional Radiology Clinic
700 Children’s Drive, T1137
Columbus, OH 43205
Phone: (614) 722-2289
Fax: (614) 722-2332
Dermatology Clinic
555 S. 18th Street
Outpatient Care Center
Columbus, OH 43205
Phone: (614) 722-5777
Fax: (614) 722-5510
Hematology/Oncology Clinic
700 Children’s Drive, H11A
Columbus, OH 43205
Phone: (614) 722-3250
Otolaryngology Clinic
555 S. 18th Street
Outpatient Care Center
Columbus, OH 43205
Phone: (614) 722-3150
Orthopedic Surgery Clinic
479 Parsons Avenue
Columbus, OH 43215
Phone: (614) 923-3874
Clinical Genetics Clinic
700 Children's Drive, Suite T4D
Columbus, OH 43205
Phone: (614) 722-3535
Psychology Clinic
700 Children’s Drive, J West 3rd Floor
Columbus, OH 43205
Phone: (614) 355-8080
Resources for Families
Hemangioma Study Seeking Participants
Who is eligible for the study?
- Is your child less than 4 months old?
- Does your child have a hemangioma that has not been previously treated?
If you answered yes to both of those questions, your child may be eligible to participate.
What do you need to know about the study?
- We are looking to find out if giving children powdered berries can make their hemangiomas shrink.
- Your child will have up to 12 study visits until your child is 18 months old.
- Participants will receive up to $600 compensation throughout study participation.
- This research study is sponsored by the National Institute of Health at Indiana University